Capital Flow Monitor · Sponsors · CIK 1745648
Apnimed, Inc.
39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA, 02138 · 877-276-4633
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$35.0M
Sold
$35.0M
% sold
100.0%
Investors
7
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-27 | D | 506(b) | $25.0M | $25.0M | 100.0% | 2 | EDGAR ↗ |
| 2025-12-08 | D/A ·current | 506(b) | $35.0M | $35.0M | 100.0% | 7 | EDGAR ↗ |
| 2025-10-01 | D/A | 506(b) | $35.0M | $35.0M | 100.0% | 7 | EDGAR ↗ |
| 2025-09-24 | D | 506(b) | $23.0M | $23.0M | 100.0% | 7 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Isaac Cheng — Director, Cambridge, MA
1 other raise
- MedRhythms, Inc. $3.3M of $5.8M · 56.0%
- Lawrence G. Miller — Executive Officer / Director, Cambridge, MA
- Barry Wohl — Executive Officer, Cambridge, MA
- Dennis Molnar — Executive Officer, Cambridge, MA
- Joseph C. Avellone — Director, Cambridge, MA
- Chris C. Dimitropoulos — Director, Cambridge, MA
-
Paul Fonteyne — Director, Cambridge, MA
3 other raises
- DalCor Pharmaceuticals US, LLC $7.0M of $7.0M · 100.0%
- Allyx Therapeutics, Inc. $26.4M of $30.0M · 88.1%
- Triton Therapeutics, Inc. $36.4M of $36.4M · 100.0%
- Kevin C. Lind — Director, Cambridge, MA
-
Gary Sender — Director, Cambridge, MA
1 other raise
- iBio, Inc. $26.0M of $26.0M · 100.0%
- Ramzi Benamar — Executive Officer, Cambridge, MA
- Francois Beaubien — Director, Cambridge, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.